Jiangsu Dekang Biotechnology Co., Ltd. is a high-tech enterprise founded by U.S.-educated biomedical experts and a controlled subsidiary of Galaxy Group. Established in 2005, it is one of the earliest specialized high-tech enterprises in China engaged in the research and development of immune cell therapy technologies and related technical services. Since its establishment, it has cooperated on immune cell technology with more than ten Grade-A tertiary hospitals; over 10,000 patients have used Dekang's technologies, with no quality incidents or doctor-patient disputes. Currently, the company focuses on the research and application of autologous cell (adipose-derived stem cell and immune cell) regenerative therapy technologies and their derivative products.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows